European Journal of Clinical and Experimental Medicine

作者在投稿时必须披露在论文写作过程中使用生成式人工智能的情况；该规定仅适用于写作过程，不涉及数据分析或研究中的AI使用；生成式AI只能用于提高可读性和语言表达，且须在人工监督下使用，作者须仔细审阅和编辑其输出，因为AI可能产生看似可信但不准确的内容。 模型中文摘要

Authors are required to disclose the use of generative AI in the writing of scientific papers upon submission. This guidance applies solely to the writing process and does not pertain to the use of AI tools for data analysis or drawing insights as part of the research process. Generative AI and AI-assisted technologies should be used in the writing process solely to enhance the readability and lan…

作者应在投稿前仔细考虑作者名单及排序，并在首次投稿时提供确定的作者名单；只有在最终录用决定之前且经期刊编辑批准，才可增删或调整作者顺序；申请此类变更时，通讯作者须向编辑提供变更理由及全体作者同意变更的书面确认（电子邮件或信函）。 模型中文摘要

Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before a final acceptance decision, and only if approved by the journal Editor. To request such a change, the …

为提高透明度并帮助读者自行判断潜在偏倚，作者必须声明与所报告研究相关的任何竞争性经济或非经济利益；竞争利益指可能直接或被认为可能影响研究客观性、完整性或解释的经济或非经济关系或情形，例如雇佣关系、咨询、持股或期权、酬金、有偿专家证言、专利等。 模型中文摘要

In the interests of transparency and to help readers form their own judgments of potential bias, authors must declare any competing financial and/or non-financial interests related to the work described. Competing interests are defined as financial or non-financial relationships or circumstances that could directly influence, or be perceived to influence, the objectivity, integrity, or interpretat…

数据可用性声明应作为单独章节（标题为“Data Availability”）置于正文末尾、参考文献之前；声明应酌情包含公开数据集的登录号、其他唯一标识符及相关网址链接，以及非公开数据集的获取条件；如提供图源数据，应在声明中予以确认。 模型中文摘要

The statement should be provided as a separate section (titled 'Data Availability') at the end of the main text, before the 'References' section. Data availability statements should include, where applicable, accession codes, other unique identifiers and associated web links for publicly available datasets, and any conditions for access of non-publicly available datasets. Where figure source data …

期刊遵循COPE指南处理学术不端指控（如剽窃、数据伪造/篡改、不道德研究、作者身份操纵、同行评审操纵）；指控可向编辑部报告，主编（或无利益冲突的受委派编辑）将进行初步评估，并在适当时要求作者解释和提供原始数据、咨询独立专家或联系作者所在机构；如指控属实，期刊可能发布关注声明、更正或撤稿。 模型中文摘要

The journal follows COPE guidance for handling allegations of misconduct (e.g., plagiarism, data fabrication/falsification, unethical research, authorship manipulation, peer-review manipulation). Allegations may be reported to the Editorial Office. The Editor-in-Chief (or a delegated editor without conflicts of interest) will conduct an initial assessment and, when appropriate, request explanation…

期刊的开放获取政策符合布达佩斯开放获取倡议（BOAI）定义，文章在公共互联网上免费可用，允许用户阅读、下载、复制、分发、打印、检索、链接全文等；所有文章均以CC-BY知识共享署名许可（当前版本为CC-BY 4.0）免费开放获取，向本刊投稿即同意其作品适用CC-BY许可。 模型中文摘要

Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without fina…

期刊的开放获取政策符合布达佩斯开放获取倡议（BOAI）定义，文章在公共互联网上免费可用，允许用户阅读、下载、复制、分发、打印、检索、链接全文等；所有文章均以CC-BY知识共享署名许可（当前版本为CC-BY 4.0）免费开放获取。 模型中文摘要

Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without fina…

投稿后稿件将交由编委会成员阅读并决定是否适合本刊；属于本刊范围且初评显示技术上可靠、科学上有效的稿件将送外部评审；投稿时必须附上在其他期刊处于审稿中或已录用（in press）的相似或相关论文的副本；不符合期刊伦理政策或未达期刊标准的稿件将在同行评审前被拒稿。 模型中文摘要

Initial checks Once submitted, your manuscript will be assigned to a member of our Editorial Board, who will read the paper and decide whether it is appropriate for the journal. Manuscripts that are within scope and seem, on initial assessment, to be technically sound and scientifically valid, will be sent to external reviewers. Copies of any papers containing similar or related work under conside…

本刊允许在投稿前或同行评审期间将稿件发布于认可的预印本服务器；作者须在投稿时披露预印本的存在并提供预印本DOI或URL；预印本不被视为经同行评审的出版物，不得作为参考文献引用；文章在本刊发表后，鼓励作者更新预印本记录，提供指向最终发表版本（VoR）的清晰链接，包括文章DOI。 模型中文摘要

The Eur J Clin Exp Med permits the posting of manuscripts on recognized preprint servers prior to submission or during the peer review process. Authors must disclose the existence of any preprint version at the time of submission and provide the preprint DOI or URL. Preprints are not considered peer-reviewed publications and must not be cited as references in manuscripts submitted to the Eur J Cli…

临床试验必须遵守所有涉及人类受试者研究的政策；本刊遵循国际医学期刊编辑委员会（ICMJE）指南，要求临床试验在首个患者入组之前或当时在公共试验注册机构注册，作为考虑发表的先决条件；ICMJE将临床试验定义为前瞻性地将个人或群体分配至干预组（无论有无同期对照或比较组）以考察……的研究。 模型中文摘要

Clinical trials must comply with all policies related to research involving human subjects. Additionally, the Eur J Clin Exp Med adheres to the guidelines set by the International Committee of Medical Journal Editors (ICMJE), which mandate the registration of clinical trials in a public trials registry prior to or at the time of the first patient enrollment as a prerequisite for publication consid…